Common long-term complications of adult congenital heart disease: avoid falling in a H.E.A.P.

References

• Tutarel O, Kempny A, Alonso-Gonzalez R, et al. Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality. Eur Heart J. 2014;35:725–732.
   PubMed Web of Science ®Google Scholar
• Diller G-P, Kempny A, Alonso-Gonzalez R, et al. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation. 2015;132(22):2118–2125.
   Web of Science ®Google Scholar
• Mcmurray JJV, Adamopoulos S, Anker SD, et al. ESC committee for practice guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787–1847.
   PubMed Web of Science ®Google Scholar
• Eindhoven JA, van den bosch AE, Ruys TPE, et al. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease. J Am Coll Cardiol. 2013;62:1203–1212.
   PubMed Web of Science ®Google Scholar
• Norozi K, Wessel A, Alpers V, et al. Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery. Am J Cardiol. 2006;97:1238–1243.
   PubMed Web of Science ®Google Scholar
• Zomer AC, Vaartjes I, van der Velde ET, et al. Heart failure admissions in adults with congenital heart disease; risk factors and prognosis. Int J Cardiol. 2013;168:2487–2493.
   PubMed Web of Science ®Google Scholar
• Piran S, Veldtman G, Siu S, et al. Heart failure and ventricular dysfunction in patients with single or systemic right ventricles. Circulation. 2002;105:1189–1194.
   PubMed Web of Science ®Google Scholar
• Bolger AP, Coats AJS, Gatzoulis MA. Congenital heart disease: the original heart failure syndrome. Eur Heart J. 2003;24:970–976.
   PubMed Web of Science ®Google Scholar
• Cuypers JAAE, Menting ME, Konings EEM, et al. Unnatural history of tetralogy of Fallot: prospective follow-up of 40 years after surgical correction. Circulation. 2014;130:1944–1953.
   PubMed Web of Science ®Google Scholar
• Sojak V, Kooij M, Yazdanbakhsh A, et al. A single-centre 37-year experience with reoperation after primary repair of atrioventricular septal defect. Eur J Cardiothorac Surg. 2015 Apr 7. pii: ezv115.
   PubMedGoogle Scholar
• Lim H-G, Kim W-H, Lee JR, et al. Long-term results of the arterial switch operation for ventriculo-arterial discordance. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 2013;43:325–334.
   PubMed Web of Science ®Google Scholar
• Giannakoulas G, Dimopoulos K, Engel R, et al. Burden of coronary artery disease in adults with congenital heart disease and its relation to congenital and traditional heart risk factors. Am J Cardiol. 2009;103:1445–1450.
   PubMed Web of Science ®Google Scholar
• Diller G-P, Dimopoulos K, Okonko D, et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005;112:828–835.
   PubMed Web of Science ®Google Scholar
• Diller G-P, Dimopoulos K, Broberg CS, et al. Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. Eur Heart J. 2006;27:1737–1742.
   PubMed Web of Science ®Google Scholar
• Inuzuka R, Diller G-P, Borgia F, et al. Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium termclinical perspective. Circulation. 2012;125:250–259.
   PubMed Web of Science ®Google Scholar
• Dimopoulos K, Alonso-Gonzalez R, Thaulow E, et al. 6 - Heart failure, exercise intolerance, and physical training. In: Gatzoulis A, Webb GD, Daubeney EF, Eds. Diagnosis and management of adult congenital heart disease. 2nd ed. Saint Louis: Churchill Livingstone; 2011. p. 44–51.
   Google Scholar
• Dimopoulos K, Okonko DO, Diller G-P, et al. Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival. Circulation. 2006;113:2796–2802.
   PubMed Web of Science ®Google Scholar
• Kilner PJ, Geva T, Kaemmerer H, et al. Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology. Eur Heart J. 2010;31:794–805.
   PubMed Web of Science ®Google Scholar
• Baumgartner H, Bonhoeffer P, De Groot NMS, et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31:2915–2957.
   PubMed Web of Science ®Google Scholar
• Warnes CA, Williams RG, Bashore TM, et al. American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease), American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease. J Am Coll Cardiol. 2008;52:e143–263.
   PubMedGoogle Scholar
• Dimopoulos K, Diller G-P, Giannakoulas G, et al. Anemia in adults with congenital heart disease relates to adverse outcome. J Am Coll Cardiol. 2009;54:2093–2100.
   PubMed Web of Science ®Google Scholar
• Cotts T, Smith KR, Lu J, et al. Risk for sleep-disordered breathing in adults after atrial switch repairs for d-looped transposition of the great arteries. Pediatr Cardiol. 2014;35:888–892.
   PubMed Web of Science ®Google Scholar
• Chung ST, Hong B, Patterson L, et al. High overweight and obesity in fontan patients: A 20-Year history. Pediatr Cardiol. 2015 Sep 16. Epub ahead of print.
   Web of Science ®Google Scholar
• Quinton E, Nightingale P, Hudsmith L, et al. Prevalence of atrial tachyarrhythmia in adults after Fontan operation. Heart Br Card Soc. 2015;101:1672–1677.
   PubMed Web of Science ®Google Scholar
• Stewart RD, Pasquali SK, Jacobs JP, et al. Contemporary Fontan operation: association between early outcome and type of cavopulmonary connection. Ann Thorac Surg. 2012;93:1254–1260; discussion 1261.
   Web of Science ®Google Scholar
• Morales DLS, Dibardino DJ, Braud BE, et al. Salvaging the failing Fontan: lateral tunnel versus extracardiac conduit. Ann Thorac Surg. 2005;80:1445–1451; discussion 1451–1452.
   PubMed Web of Science ®Google Scholar
• Mongeon F-P, Connolly HM, Dearani JA, et al. Congenitally corrected transposition of the great arteries ventricular function at the time of systemic atrioventricular valve replacement predicts long-term ventricular function. J Am Coll Cardiol. 2011;57:2008–2017.
   PubMed Web of Science ®Google Scholar
• Gatzoulis MA, Clark AL, Cullen S, et al. Right ventricular diastolic function 15 to 35 years after repair of tetralogy of Fallot. Restrictive physiology predicts superior exercise performance. Circulation. 1995;91:1775–1781.
   PubMed Web of Science ®Google Scholar
• Bonello B, Kempny A, Uebing A, et al. Right atrial area and right ventricular outflow tract akinetic length predict sustained tachyarrhythmia in repaired tetralogy of Fallot. Int J Cardiol. 2013;168:3280–3286.
   PubMed Web of Science ®Google Scholar
• Dimopoulos K, Diller G-P, Koltsida E, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation. 2008;117:2320–2328.
   PubMed Web of Science ®Google Scholar
• Naeije R, Manes A. The right ventricle in pulmonary arterial hypertension. Eur Respir Rev. 2014;23:476–487.
   PubMedGoogle Scholar
• Bansal S, Lindenfeld J, Schrier RW. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist? Circ Heart Fail. 2009;2:370–376.
   PubMed Web of Science ®Google Scholar
• Dimopoulos K, Diller G-P, Petraco R, et al. Hyponatraemia: A strong predictor of mortality in adults with congenital heart disease. Eur Heart J. 2010;31:595–601.
   PubMed Web of Science ®Google Scholar
• van der Bom T, Winter MM, Bouma BJ, et al. Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial. Circulation. 2013;127:322–330.
   PubMed Web of Science ®Google Scholar
• Babu-Narayan SV, Uebing A, Davlouros PA, et al. Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation: the APPROPRIATE study (Ace inhibitors for Potential PRevention Of the deleterious effects of Pulmonary Regurgitation In Adults with repaired TEtralogy of Fallot). Int J Cardiol. 2012;154:299–305.
   PubMed Web of Science ®Google Scholar
• Norozi K, Bahlmann J, Raab B, et al. A prospective, randomized, double-blind, placebo controlled trial of beta-blockade in patients who have undergone surgical correction of tetralogy of Fallot. Cardiol Young. 2007;17:372–379.
   PubMed Web of Science ®Google Scholar
• Giardini A, Lovato L, Donti A, et al. A pilot study on the effects of carvedilol on right ventricular remodelling and exercise tolerance in patients with systemic right ventricle. Int J Cardiol. 2007;114:241–246.
   PubMed Web of Science ®Google Scholar
• Doughan ARK, McConnell ME, Book WM. Effect of beta blockers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle. Am J Cardiol. 2007;99:704–706.
   PubMed Web of Science ®Google Scholar
• Dos L, Pujadas S, Estruch M, et al. Eplerenone in systemic right ventricle: Double blind randomized clinical trial. The evedes study. Int J Cardiol. 2013;168:5167–5173.
   PubMed Web of Science ®Google Scholar
• Janousek J, Gebauer RA, Abdul-Khaliq H, et al. Working group for cardiac dysrhythmias and electrophysiology of the association for European Paediatric Cardiology. Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates. Heart Br Card Soc. 2009;95:1165–1171.
   PubMed Web of Science ®Google Scholar
• Dubin AM, Janousek J, Rhee E, et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol. 2005;46:2277–2283.
   PubMed Web of Science ®Google Scholar
• Cecchin F, Frangini PA, Brown DW, et al. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. J Cardiovasc Electrophysiol. 2009;20:58–65.
   PubMed Web of Science ®Google Scholar
• Khairy P, Van Hare GF, Balaji S, et al. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Can J Cardiol. 2014;30:e1–e63.
   PubMed Web of Science ®Google Scholar
• Diller G-P, Okonko D, Uebing A, et al. Cardiac resynchronization therapy for adult congenital heart disease patients with a systemic right ventricle: analysis of feasibility and review of early experience. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2006;8:267–272.
   Google Scholar
• Kaszala K, Ellenbogen KA. When right may not be right: right bundle-branch block and response to cardiac resynchronization therapy. Circulation. 2010;122:1999–2001.
   PubMed Web of Science ®Google Scholar
• Merchant FM, Kella D, Book WM, et al. Cardiac resynchronization therapy in adult patients with repaired tetralogy of fallot and left ventricular systolic dysfunction. Pacing Clin Electrophysiol PACE. 2014;37:321–328.
   PubMed Web of Science ®Google Scholar
• Karamlou T, Hirsch J, Welke K, et al. A united network for organ sharing analysis of heart transplantation in adults with congenital heart disease: outcomes and factors associated with mortality and retransplantation. J Thorac Cardiovasc Surg. 2010;140:161–168.
   PubMed Web of Science ®Google Scholar
• Davies RR, Russo MJ, Yang J, et al. Listing and transplanting adults with congenital heart disease. Circulation. 2011;123:759–767.
   PubMed Web of Science ®Google Scholar
• Robinson JA, Driscoll DJ, O’Leary PW, et al. Cardiac and multiorgan transplantation for end-stage congenital heart disease. Mayo Clin Proc. 2014;89:478–483.
   PubMed Web of Science ®Google Scholar
• Mulukutla V, Franklin WJ, Villa CR, et al. Surgical device therapy for heart failure in the adult with congenital heart disease. Heart Fail Clin. 2014;10:197–206.
   PubMed Web of Science ®Google Scholar
• Shah NR, Lam WW, Rodriguez FH, et al. Clinical outcomes after ventricular assist device implantation in adults with complex congenital heart disease. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2013;32:615–620.
   PubMed Web of Science ®Google Scholar
• Peng E, O’Sullivan JJ, Griselli M, et al. Durable ventricular assist device support for failing systemic morphologic right ventricle: early results. Ann Thorac Surg. 2014;98:2122–2129.
   PubMed Web of Science ®Google Scholar
• Di Molfetta A, Ferrari G, Filippelli S, et al. Use of ventricular assist device in univentricular physiology: the role of lumped parameter models. Artif Organs. 2015 Oct 23. DOI:10.1111/aor.12583.
   Google Scholar
• Halaweish I, Ohye RG, Si MS. Berlin heart ventricular assist device as a long-term bridge to transplantation in a Fontan patient with failing single ventricle. Pediatr Transplant. 2015 Sep 26. DOI:10.1111/petr.12607.
   PubMed Web of Science ®Google Scholar
• Moller JH, Anderson RC. 1,000 consecutive children with a cardiac malformation with 26- to 37-year follow-up. Am J Cardiol. 1992;70:661–667.
   PubMed Web of Science ®Google Scholar
• Li W, Somerville J. Infective endocarditis in the grown-up congenital heart (GUCH) population. Eur Heart J. 1998;19:166–173.
   PubMed Web of Science ®Google Scholar
• Mcelhinney DB, Benson LN, Eicken A, et al. Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European studies. Circ Cardiovasc Interv. 2013;6:292–300.
   PubMed Web of Science ®Google Scholar
• Van Dijck I, Budts W, Cools B, et al. Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants. Heart Br Card Soc. 2015;101:788–793.
   PubMed Web of Science ®Google Scholar
• Knirsch W, Haas NA, Uhlemann F, et al. Clinical course and complications of infective endocarditis in patients growing up with congenital heart disease. Int J Cardiol. 2005;101:285–291.
   PubMed Web of Science ®Google Scholar
• Di Filippo S, Delahaye F, Semiond B, et al. Current patterns of infective endocarditis in congenital heart disease. Heart Br Card Soc. 2006;92:1490–1495.
   PubMed Web of Science ®Google Scholar
• Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC): Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–3128.
   Google Scholar
• Moons P, De Volder E, Budts W, et al. What do adult patients with congenital heart disease know about their disease, treatment, and prevention of complications? A call for structured patient education. Heart Br Card Soc. 2001;86:74–80.
   PubMed Web of Science ®Google Scholar
• Opotowsky AR, Siddiqi OK. Webb GD. Trends in hospitalizations for adults with congenital heart disease in the U.S. J Am Coll Cardiol. 2009;54:460–467.
   PubMed Web of Science ®Google Scholar
• Bouchardy J, Therrien J, Pilote L, et al. Atrial arrhythmias in adults with congenital heart disease. Circulation. 2009;120:1679–1686.
   PubMed Web of Science ®Google Scholar
• Barber BJ, Batra AS, Burch GH, et al. Acute hemodynamic effects of pacing in patients with Fontan physiology: a prospective study. J Am Coll Cardiol. 2005;46:1937–1942.
   PubMed Web of Science ®Google Scholar
• Walker F, Siu SC, Woods S, et al. Long-term outcomes of cardiac pacing in adults with congenital heart disease. J Am Coll Cardiol. 2004;43:1894–1901.
   PubMed Web of Science ®Google Scholar
• Khairy P, Landzberg MJ, Gatzoulis MA, et al. Epicardial Versus ENdocardial pacing and Thromboembolic events Investigators. Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study. Circulation. 2006;113:2391–2397.
   PubMed Web of Science ®Google Scholar
• Cecchin F, Johnsrude CL, Perry JC, et al. Effect of age and surgical technique on symptomatic arrhythmias after the Fontan procedure. Am J Cardiol. 1995;76:386–391.
   PubMed Web of Science ®Google Scholar
• Stamm C, Friehs I, Mayer JE, et al. Del Nido PJ null. Long-term results of the lateral tunnel Fontan operation. J Thorac Cardiovasc Surg. 2001;121:28–41.
   PubMed Web of Science ®Google Scholar
• Roldán V, Marín F, Manzano-Fernández S, et al. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol. 2013;62:2199–2204.
   PubMed Web of Science ®Google Scholar
• Ueda A, Suman-Horduna I, Mantziari L, et al. Contemporary outcomes of supraventricular tachycardia ablation in congenital heart disease: a single-center experience in 116 patients. Circ Arrhythm Electrophysiol. 2013;6:606–613.
   PubMed Web of Science ®Google Scholar
• Triedman JK, Alexander ME, Love BA, et al. Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 2002;39:1827–1835.
   PubMed Web of Science ®Google Scholar
• Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36:2793–2867.
   PubMed Web of Science ®Google Scholar
• Nollert G, Fischlein T, Bouterwek S, et al. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol. 1997;30:1374–1383.
   PubMed Web of Science ®Google Scholar
• Khairy P, Harris L, Landzberg MJ, et al. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation. 2008;117:363–370.
   PubMed Web of Science ®Google Scholar
• Koyak Z, De Groot JR, Van Gelder IC, et al. Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks? Circ Arrhythm Electrophysiol. 2012;5:101–110.
   PubMed Web of Science ®Google Scholar
• Radbill AE, Triedman JK, Berul CI, et al. System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients. Heart Rhythm Off J Heart Rhythm Soc. 2010;7:193–198.
   PubMed Web of Science ®Google Scholar
• Galiè N, Humbert M, Vachiery J-L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46:903–975.
   Web of Science ®Google Scholar
• Dimopoulos K, Wort SJ, Gatzoulis MA. Pulmonary hypertension related to congenital heart disease: a call for action. Eur Heart J. 2014;35:691–700.
   PubMed Web of Science ®Google Scholar
• Manes A, Palazzini M, Leci E, et al. Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. Eur Heart J. 2014;35:716–724.
   PubMed Web of Science ®Google Scholar
• Diller G-P, Kempny A, Inuzuka R, et al. Survival prospects of treatment naïve patients with Eisenmenger: a systematic review of the literature and report of own experience. Heart Br Card Soc. 2014;100:1366–1372.
   PubMed Web of Science ®Google Scholar
• Tay ELW, Peset A, Papaphylactou M, et al. Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome. Int J Cardiol. 2011;151:307–312.
   PubMed Web of Science ®Google Scholar
• Ammash N, Warnes CA. Cerebrovascular events in adult patients with cyanotic congenital heart disease. J Am Coll Cardiol. 1996;28:768–772.
   PubMed Web of Science ®Google Scholar
• Spence MS, Balaratnam MS, Gatzoulis MA. Clinical update: cyanotic adult congenital heart disease. Lancet. 2007;370:1530–1532.
   PubMed Web of Science ®Google Scholar
• Bédard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J. 2009;30:256–265.
   PubMed Web of Science ®Google Scholar
• Gatzoulis MA, Beghetti M, Landzberg MJ, et al. Pulmonary arterial hypertension associated with congenital heart disease: recent advances and future directions. Int J Cardiol. 2014;177:340–347.
   PubMed Web of Science ®Google Scholar
• Broberg CS, Ujita M, Prasad S, et al. Pulmonary arterial thrombosis in eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity. J Am Coll Cardiol. 2007;50:634–642.
   PubMed Web of Science ®Google Scholar
• Kempny A, Dimopoulos K, Uebing A, et al. Reference values for exercise limitations among adults with congenital heart disease. Relation to activities of daily life–single centre experience and review of published data. Eur Heart J. 2012;33:1386–1396.
   PubMed Web of Science ®Google Scholar
• Budts W, Börjesson M, Chessa M, et al. Physical activity in adolescents and adults with congenital heart defects: individualized exercise prescription. Eur Heart J. 2013;34:3669–3674.
   PubMed Web of Science ®Google Scholar
• Galiè N, Beghetti M, Gatzoulis MA, et al. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation. 2006;114:48–54.
   PubMed Web of Science ®Google Scholar
• Gatzoulis MA, Beghetti M, Galiè N, et al. Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study. Int J Cardiol. 2008;127:27–32.
   PubMed Web of Science ®Google Scholar
• Singh TP, Rohit M, Grover A, et al. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. Am Heart J. 2006;151:851.e1–5.
   Web of Science ®Google Scholar
• Mukhopadhyay S, Nathani S, Yusuf J, et al. Clinical efficacy of phosphodiesterase-5 inhibitor tadalafil in Eisenmenger syndrome–a randomized, placebo-controlled, double-blind crossover study. Congenit Heart Dis. 2011;6:424–431.
   PubMed Web of Science ®Google Scholar
• Simonneau G, Barst RJ, Galie N, et al. Treprostinil study group. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2002;165:800–804.
   PubMed Web of Science ®Google Scholar
• Galiè N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005;353:2148–2157.
   PubMed Web of Science ®Google Scholar
• Barst RJ, Langleben D, Frost A, et al. STRIDE-1 Study Group. Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med. 2004;169:441–447.
   PubMed Web of Science ®Google Scholar
• Galiè N, Rubin L, Hoeper M, et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet. 2008;371:2093–2100.
   PubMed Web of Science ®Google Scholar
• Diller G-P, Alonso-Gonzalez R, Dimopoulos K, et al. Disease targeting therapies in patients with Eisenmenger syndrome: Response to treatment and long-term efficiency. Int J Cardiol. 2013;167:840–847.
   PubMed Web of Science ®Google Scholar
• Apostolopoulou SC, Manginas A, Cokkinos DV, et al. Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study. Heart Br Card Soc. 2007;93:350–354.
   PubMed Web of Science ®Google Scholar
• Rosenzweig EB, Kerstein D, Barst RJ. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation. 1999;99:1858–1865.
   PubMed Web of Science ®Google Scholar
• Galiè N, Barberà JA, Frost AE, et al. AMBITION Investigators. Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. N Engl J Med. 2015;373:834–844.
   PubMed Web of Science ®Google Scholar
• Pulido T, Adzerikho I, Channick RN, et al. SERAPHIN Investigators. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med. 2013;369:809–818.
   PubMed Web of Science ®Google Scholar
• Iversen K, Jensen AS, Jensen TV, et al. Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial. Eur Heart J. 2010;31:1124–1131.
   PubMed Web of Science ®Google Scholar
• Moceri P, Kempny A, Liodakis E, et al. Physiological differences between various types of Eisenmenger syndrome and relation to outcome. Int J Cardiol. 2015;179:455–460.
   PubMed Web of Science ®Google Scholar